Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer

被引:369
作者
Grills, Inga S. [1 ]
Mangona, Victor S.
Welsh, Robert
Chmielewski, Gary
McInerney, Erika
Martin, Shannon
Wloch, Jennifer
Ye, Hong
Kestin, Larry L.
机构
[1] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA
关键词
RADIATION-THERAPY; SUBLOBAR RESECTION; LOBECTOMY; BRACHYTHERAPY; CARCINOMA;
D O I
10.1200/JCO.2009.25.0928
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose To compare outcomes between lung stereotactic radiotherapy (SBRT) and wedge resection for stage I non-small-cell lung cancer (NSCLC). Patients and Methods One hundred twenty-four patients with T1-2N0 NSCLC underwent wedge resection (n = 69) or image-guided lung SBRT (n = 58) from February 2003 through August 2008. All were ineligible for anatomic lobectomy; of those receiving SBRT, 95% were medically inoperable, with 5% refusing surgery. Mean forced expiratory volume in 1 second and diffusing capacity of lung for carbon monoxide were 1.39 L and 12.0 mL/min/mmHg for wedge versus 1.31 L and 10.14 mL/min/mmHg for SBRT (P = not significant). Mean Charlson comorbidity index and median age were 3 and 74 years for wedge versus 4 and 78 years for SBRT (P < .01, P = .04). SBRT was volumetrically prescribed as 48 (T1) or 60 (T2) Gy in four to five fractions. Results Median potential follow-up is 2.5 years. At 30 months, no significant differences were identified in regional recurrence (RR), locoregional recurrence (LRR), distant metastasis (DM), or freedom from any failure (FFF) between the two groups (P > .16). SBRT reduced the risk of local recurrence (LR), 4% versus 20% for wedge (P = .07). Overall survival (OS) was higher with wedge but cause-specific survival (CSS) was identical. Results excluding synchronous primaries, nonbiopsied tumors, or pathologic T4 disease (wedge satellite lesion) showed reduced LR (5% v 24%, P = .05), RR (0% v 18%, P = .07), and LRR (5% v 29%, P = .03) with SBRT. There were no differences in DM, FFF, or CSS, but OS was higher with wedge. Conclusion Both lung SBRT and wedge resection are reasonable treatment options for stage I NSCLC patients ineligible for anatomic lobectomy. SBRT reduced LR, RR, and LRR. In this nonrandomized population of patients selected for surgery versus SBRT (medically inoperable) at physician discretion, OS was higher in surgical patients. SBRT and surgery, however, had identical CSS.
引用
收藏
页码:928 / 935
页数:8
相关论文
共 21 条
[1]
[Anonymous], 1995, Ann. Thorac. Surg, DOI 10.1016/0003-4975
[2]
Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer [J].
Birdas, TJ ;
Koehler, RPM ;
Colonias, A ;
Trombetta, M ;
Maley, RH ;
Landreneau, RJ ;
Keenan, RJ .
ANNALS OF THORACIC SURGERY, 2006, 81 (02) :434-439
[3]
RADIATION-THERAPY IN THE MANAGEMENT OF MEDICALLY INOPERABLE CARCINOMA OF THE LUNG - RESULTS AND IMPLICATIONS FOR FUTURE TREATMENT STRATEGIES [J].
DOSORETZ, DE ;
KATIN, MJ ;
BLITZER, PH ;
RUBENSTEIN, JH ;
SALENIUS, S ;
RASHID, M ;
DOSANI, RA ;
MESTAS, G ;
SIEGEL, AD ;
CHADHA, TT ;
CHANDRAHASA, T ;
HANNAN, SE ;
BHAT, SB ;
METKE, MP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (01) :3-9
[4]
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis [J].
El-Sherif, Amgad ;
Gooding, William E. ;
Santos, Ricardo ;
Pettiford, Brian ;
Ferson, Peter F. ;
Fernando, Hiran C. ;
Urda, Susan J. ;
Luketich, James D. ;
Landreneau, Rodney J. .
ANNALS OF THORACIC SURGERY, 2006, 82 (02) :408-416
[5]
STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY [J].
Fakiris, Achilles J. ;
McGarry, Ronald C. ;
Yiannoutsos, Constantin T. ;
Papiez, Lech ;
Williams, Mark ;
Henderson, Mark A. ;
Timmerman, Robert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :677-682
[6]
Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy [J].
Grills, Inga S. ;
Hugo, Geoffrey ;
Kestfn, Larry L. ;
Galerani, Ana Paula ;
Chao, K. Kenneth ;
Wloch, Jennifer ;
Yan, Di .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :1045-1056
[7]
Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer [J].
Jeremic, B ;
Shibamoto, Y ;
Acimovic, L ;
Milisavljevic, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03) :521-525
[8]
Segmental resection spares pulmonary function in patients with stage I lung cancer [J].
Keenan, RJ ;
Landreneau, RJ ;
Maley, RH ;
Singh, D ;
Macherey, R ;
Bartley, S ;
Santucci, T .
ANNALS OF THORACIC SURGERY, 2004, 78 (01) :228-233
[9]
Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation? [J].
Krol, ADG ;
Aussems, P ;
Noordijk, EM ;
Hermans, J ;
Leer, JWH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02) :297-302
[10]
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer [J].
Landreneau, RJ ;
Sugarbaker, DJ ;
Mack, MJ ;
Hazelrigg, SR ;
Luketich, JD ;
Fetterman, L ;
Liptay, MJ ;
Bartley, S ;
Boley, TM ;
Keenan, RJ ;
Ferson, PF ;
Weyant, RJ ;
Naunheim, KS .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (04) :691-700